Scientists uncover how part of a protein helps primates fight HIV

January 14, 2016
HIV (yellow) infecting a human immune cell. Credit: Seth Pincus, Elizabeth Fischer and Austin Athman, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Scientists have uncovered part of a protein found in humans and other primates that can help us fight off HIV. In a new study published in the journal Heliyon, researchers discover how this structure can stop HIV from working and switch on our immune system at the same time. The findings, say the authors of the study, could potentially be used in developing anti-HIV gene therapy in the future.

All primates - including humans - have a protein called TRIM5alpha. This protein can intercept HIV and related viruses and stop them from replicating and infecting more cells. It can also switch on the immune system, helping us fight HIV infection. Scientists have previously identified different parts of the TRIM5alpha protein that are responsible for the protein's ability to fight HIV.

The researchers behind the new study believe the protein switches on the immune system by attaching to another protein called "SUMO." However, two of the structures that could potentially attach to SUMO proteins are hidden inside TRIM5alpha, making it impossible for them to attach.

In the new study, researchers from Université du Québec à Trois-Rivières in Canada, the University of Colorado Boulder, and Albert Einstein College of Medicine in the United States have identified a new part of the TRIM5alpha protein that could attach to SUMO and thereby activate an . They call it SIM4, or "SUMO interacting motif 4".

"HIV-1 inhibition by restriction factors is fascinating as a natural antiviral system," said Dr. Berthoux, corresponding author of the study from Université du Québec à Trois-Rivières. "Our new findings contribute to mapping how our immune systems are activated against retroviruses like HIV."

Dr. Berthoux and the team analyzed SIM4 to see if it does indeed have an effect on how we fight HIV. They found that when SIM4 is mutated, the TRIM5alpha can no longer attach to HIV or stop it from working. This finding suggests that SIM4 is vital for arming TRIM5alpha against HIV.

TRIM5alpha can be used in to treating HIV infection. With this approach, the could be activated, causing unwanted side effects. According to the researchers, using genes with mutations that stop this activation could be one way to optimize gene therapy.

"Our cells can mount a surprisingly complex response to viral infections," added Dr. Berthoux. "Finding a way to tweak the activity of these antiviral factors so that they target HIV, or other viruses of interest, is a valuable avenue of research."

Explore further: Targeting HIV 'reservoir' could be first step to understanding how to cure the disease

More information: "A putative SUMO interacting motif in the B30.2/SPRY domain of rhesus macaque TRIM5α important for NF-κB/AP-1 signaling and HIV-1 restriction" by Marie-Édith Nepveu-Traversy et al. (www.heliyon.com/article/e00056/ ). The article appears in Heliyon (January 2016) dx.doi.org/10.1016/j.heliyon.2015.e00056

Related Stories

Targeting HIV 'reservoir' could be first step to understanding how to cure the disease

December 1, 2015
A new clinical trial will test whether it is possible to destroy hidden reservoirs of HIV virus that are a key obstacle to curing the disease.

Scientists find surprising trait in anti-HIV antibodies

November 17, 2015
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.

Cellular pathway discovered that may re-energize immune cells to eliminate HIV

January 12, 2016
Researchers at the University of Hawai'i (UH) and Oregon Health Sciences University (OHSU) have revealed a novel new immune pathway that can be targeted to increase the immune system's ability to eliminate HIV, the virus ...

Discovery may help prevent HIV 'reservoirs' from forming

April 17, 2013
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the protein that blocks HIV-1 from multiplying in white blood cells is regulated. HIV-1 is the virus that causes AIDS, and the discovery ...

HIV cure research: Scientists create two-headed protein to deplete HIV reservoir

October 20, 2015
Scientists at the National Institutes of Health (NIH) have created a protein that awakens resting immune cells infected with HIV and facilitates their destruction in laboratory studies. The protein potentially could contribute ...

Scientists find the invisibility cloak that shields HIV-1 from the immune system

November 21, 2013
Of the two major types of HIV, only one, HIV-1, typically causes AIDS in infected people who don't receive treatment. A study published by Cell Press November 21st in the journal Immunity reveals how HIV-1 escapes detection ...

Recommended for you

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

Heart toxin reveals new insights into HIV-1 integration in T cell genome

July 20, 2017
Human immunodeficiency virus (HIV)-1 may have evolved to integrate its genetic material into certain immune-cell-activating genes in humans, according to new research published in PLOS Pathogens.

Scientists capture first high-resolution image of key HIV protein transitional state

July 13, 2017
A new, three-dimensional snapshot of HIV demonstrates the radical structural transformations that enable the virus to recognize and infect host cells, according to a new study led by scientists at The Scripps Research Institute ...

Barrier to autoimmune disease may open door to HIV, study suggests

July 11, 2017
Researchers from the University of Colorado School of Medicine have discovered that a process that protects the body from autoimmune disease also prevents the immune system from generating antibodies that can neutralize the ...

Team tests best delivery mode for potential HIV vaccine

June 20, 2017
For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.